The BET1 Knockout HeLa Polyclonal Cells are a population of HeLa cells subjected to CRISPR/Cas9-mediated disruption of the BET1 gene, generating a heterogeneous pool with reduced BET1 function. This polyclonal knockout model facilitates population-based studies of ER-Golgi SNARE-dependent trafficking without the biases of single-cell cloning. BET1 encodes a Qb-SNARE essential for COPII vesicle tethering and fusion, making this product a valuable tool for dissecting anterograde transport mechanisms.
The HeLa host cell line originates from HPV18-positive cervical adenocarcinoma and is a widely used epithelial cancer model with robust, characterized secretory pathway activity. Its tumor-derived background and genetic tractability make it particularly suitable for investigating the interplay between oncogenesis and membrane trafficking. HeLa cells provide a consistent platform for analyzing the role of BET1 in maintaining Golgi organization and secretory flux in a cancer context.
BET1 forms a core SNARE complex with STX5, GOSR1, SEC22B, and BNIP1, which specifically drives the docking and fusion of COPII vesicles??coated by SEC23/SEC24, SEC13/SEC31, and activated by SAR1??with the cis-Golgi. This function is subject to upstream regulation by ER stress signals and cell cycle machinery, while downstream consequences include modulation of Golgi integrity and secretory pathway throughput. Loss of BET1 disrupts this coordinated interaction, providing a direct means to probe SNARE assembly and cargo delivery.
In the HeLa context, BET1 knockout addresses the increased reliance of cancer cells on efficient secretion for growth factor receptor delivery and extracellular matrix remodeling. The HPV18-positive status further invites exploration of viral manipulation of host trafficking pathways. By uncoupling COPII tethering from Golgi membrane fusion, researchers can study adaptive responses to ER-Golgi transport stress and identify vulnerabilities in the secretory infrastructure of tumor cells.
Key applications include western blotting and immunofluorescence for assessing BET1 expression and Golgi morphology, co-immunoprecipitation to analyze SNARE complex formation, and the VSVG-ts045 assay to track ER-to-Golgi transport kinetics. Secretion assays and RNAi rescue experiments further enable functional validation. These polyclonal knockout cells are ideally suited for investigations in cancer cell biology, secretory pathway dynamics, and host-pathogen interactions. For additional information, please contact Ascent Research.
